Successful treatment of pulmonary hemangioma with propranolol

Pulmonary hemangioma is a rare benign tumor of the lungs. Airway hemangiomas in particular may lead to feeding difficulties, barking cough, stridor, respiratory distress, and even acute airway obstruction. Hence, such hemangiomas usually require early and aggressive treatment; however, the treatment modalities employed so far have been associated with their own co‐morbidities and potential long‐term adverse effects for the developing child. Here, we report a case of 9‐month‐old girl who presented with dyspnea and diagnosed pulmonary hemangioma in the lower lobe of left lung. Propranolol is now used as a first line treatment for infantile hemangiomas by many practitioners so we experienced propranolol treatment. This case report argues the first case of pulmonary hemangioma treated with propranolol successfully. Pediatr Pulmonol. 2014; 49:829–833. © 2014 Wiley Periodicals, Inc.

[1]  Juan Xie,et al.  The effectiveness of propranolol in treating infantile haemangiomas: a meta‐analysis including 35 studies , 2014, British journal of clinical pharmacology.

[2]  Z. N. D. de Oliveira,et al.  Propranolol for treatment of infantile hemangiomas* , 2013, Anais brasileiros de dermatologia.

[3]  Wei-min Li,et al.  Pulmonary sclerosing hemangioma: a unique epithelial neoplasm of the lung (report of 26 cases) , 2013, World Journal of Surgical Oncology.

[4]  C. Price,et al.  Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. , 2011, Archives of dermatology.

[5]  Swee T Tan,et al.  Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution. , 2011, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[6]  R. Pandya,et al.  Giant infantile pulmonary hemangioma , 2010, Pediatric Radiology.

[7]  J. Zippin,et al.  Current treatments for infantile hemangiomas. , 2010, Journal of drugs in dermatology : JDD.

[8]  D. Lipsker,et al.  Propranolol for Severe Infantile Hemangiomas: Follow-Up Report , 2009, Pediatrics.

[9]  J. L. Todd,et al.  Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations , 2009, Pediatric dermatology.

[10]  F. Boralevi,et al.  Propranolol for severe hemangiomas of infancy. , 2008, The New England journal of medicine.

[11]  J. Petty,et al.  A unique case of a giant congenital pulmonary hemangioma in a newborn. , 2008, Journal of pediatric surgery.

[12]  I. Frieden,et al.  Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. , 2007, The Journal of pediatrics.

[13]  D. Siegel,et al.  Infantile Hemangiomas: Current Knowledge, Future Directions. Proceedings of a Research Workshop on Infantile Hemangiomas , 2005, Pediatric dermatology.

[14]  I. Frieden,et al.  Hemangiomas of infancy. , 2003, Journal of the American Academy of Dermatology.

[15]  M. Bogović,et al.  Sclerosing Haemangioma of the Lung in a 4-Year-Old Child , 2002, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.

[16]  A. Fleischer,et al.  Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. , 2001, Archives of dermatology.

[17]  W. Travis,et al.  A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. , 2000, The American journal of surgical pathology.

[18]  O. Enjolras,et al.  Superficial Hemangiomas: Associations and Management , 1997, Pediatric dermatology.

[19]  A. Margileth,et al.  Cutaneous hemangiomas in children. Diagnosis and conservative management. , 1965, JAMA.